NovoCure Ltd (NVCR)
12.39
+0.16
(+1.31%)
USD |
NASDAQ |
Apr 26, 09:53
NovoCure Price: 12.39 for April 26, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Apr 25, 2024 | 12.36 | 12.37 | 11.88 | 12.23 | 1.008M |
Apr 24, 2024 | 12.09 | 12.39 | 12.02 | 12.34 | 1.317M |
Apr 23, 2024 | 11.70 | 12.46 | 11.70 | 12.06 | 839660.0 |
Apr 22, 2024 | 12.19 | 12.19 | 11.70 | 11.83 | 809482.0 |
Apr 19, 2024 | 11.89 | 12.32 | 11.89 | 12.09 | 850446.0 |
Apr 18, 2024 | 12.05 | 12.44 | 11.89 | 12.05 | 1.392M |
Apr 17, 2024 | 12.40 | 12.45 | 12.04 | 12.05 | 1.361M |
Apr 16, 2024 | 12.56 | 12.71 | 12.20 | 12.46 | 923876.0 |
Apr 15, 2024 | 13.60 | 13.72 | 12.63 | 12.72 | 1.168M |
Apr 12, 2024 | 14.01 | 14.12 | 13.40 | 13.57 | 901798.0 |
Apr 11, 2024 | 14.90 | 15.00 | 14.02 | 14.12 | 831697.0 |
Apr 10, 2024 | 14.48 | 14.74 | 14.11 | 14.62 | 1.028M |
Apr 09, 2024 | 14.20 | 15.46 | 14.18 | 14.88 | 969689.0 |
Apr 08, 2024 | 13.80 | 14.21 | 13.62 | 14.18 | 1.131M |
Apr 05, 2024 | 14.06 | 14.24 | 13.62 | 13.74 | 1.390M |
Apr 04, 2024 | 14.60 | 14.78 | 14.22 | 14.29 | 1.174M |
Apr 03, 2024 | 14.08 | 14.79 | 14.00 | 14.42 | 1.365M |
Apr 02, 2024 | 15.12 | 15.15 | 14.07 | 14.39 | 1.389M |
Apr 01, 2024 | 15.63 | 15.63 | 14.98 | 15.49 | 1.674M |
Mar 28, 2024 | 14.55 | 16.05 | 14.38 | 15.63 | 2.812M |
Mar 27, 2024 | 14.78 | 15.54 | 12.92 | 14.64 | 11.94M |
Mar 26, 2024 | 13.43 | 13.57 | 13.04 | 13.07 | 1.094M |
Mar 25, 2024 | 13.19 | 13.61 | 12.89 | 13.20 | 1.376M |
Mar 22, 2024 | 13.74 | 13.95 | 13.08 | 13.21 | 953527.0 |
Mar 21, 2024 | 13.77 | 14.04 | 13.55 | 13.95 | 1.052M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
11.13
Minimum
Nov 10 2023
225.58
Maximum
Jun 23 2021
83.47
Average
77.02
Median
Price Benchmarks
AtriCure Inc | 22.63 |
NeuroMetrix Inc | 4.10 |
Repligen Corp | 166.54 |
Teleflex Inc | 207.40 |
Perspective Therapeutics Inc | 1.57 |
Price Related Metrics
PS Ratio | 2.588 |
PEG Ratio | -0.0523 |
Price to Book Value | 3.678 |
Earnings Yield | -15.74% |
Market Cap | 1.333B |
PEGY Ratio | -0.0523 |